SHENZHEN, China and NEW DELHI, India, Sept. 6, 2019 -- MGI announced it has partnered with Imperial Life Sciences (ILS), a key player in the Indian life science market with extensive experience representing global companies, as its exclusive distributor in India. Within the first month of collaboration, the MGI-ILS team has already placed several MGI sequencers in India and has plans to sell many more systems in 2019. These initial sales are strategically placed, covering both leading clinical diagnostic and research market segments.
MGI will establish its first demo lab at ILS in Gurugram, where this month it will install MGI sequencing instruments, including the MGISEQ-200 genetic sequencer and MGISP-100 automated workstation specialized for NGS applications. The demo lab will focus on NIPT, clinical WES, metagenomics and cancer panels, and conduct workshops and training. MGI plans to invite leaders from the diagnostic and research industries and academic sectors to the lab to demonstrate data QC from MGI sequencer. MGI is in the process of training ILS engineers to provide after sales services and advanced application training to the ILS FAS team for complete application support within country.
“MGI is glad to be working with such a well-established distributor as we expand our presence to serve customers in India. We believe with this partnership we will be able to reach and offer MGI’s advanced sequencing solutions to each and every researcher across this great country,” said Fang Xiao, General Manager of Asia Pacific at MGI.
“ILS is excited about this partnership with MGI, as it offers an excellent combination of advanced technology, accurate results, extensive ready-to-use assays and a highly affordable price point for the Indian market, with much needed flexibility of sequencing throughput,” said Neeraj Gupta, Director of Sales & Marketing at ILS.
For the last 27 years, ILS has been the exclusive representative of many leading global companies. ILS provides complete solutions in research instrumentation, reagents, bio-informatics, consumables and molecular diagnostics, with a complete range of products for genomics, molecular diagnostics, cell biology and imaging. ILS continually strives to provide innovative value-added solutions to the Indian Life Science market by collaborating with researchers in all stages of their projects.
ILS will help drive marketing efforts in India with their depth of experience in the local market. Seminars about MGI will be conducted in several major cities in October and November. ILS and MGI will be jointly participating in the upcoming TCGA and NGBT conferences in September in Pune and Mumbai, respectively, planned as MGI’s premier conferences in India, where MGI will showcase its MGISEQ-200 and MGISEQ-2000 sequencers. ILS will also promote the MGI brand and products across the country.